Arcutis (ARQT) Q1 2026 Earnings Transcript
Source: Motley Fool
2026-05-07 09:17:32 ET
Image source: The Motley Fool.
Wednesday, May 6, 2026 at 4:30 p.m. ET
Need a quote from a Motley Fool analyst? Email pr@fool.com
Arcutis Biotherapeutics Inc.
NASDAQ: ARQT
ARQT Trading
-1.95% G/L:
$26.89 Last:
429,206 Volume:
$27.25 Open:
ARQT Latest News
July 08, 2026 08:00:00 am
FDA Accepts Supplemental New Drug Application for Arcutis' ZORYVE® (roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months
July 03, 2026 08:57:20 am
Arcutis vs. Vertex: Which Pharmaceutical Maker Stock Is a Better Buy in 2026?
$3,301,042,082
98,483,722
0.17%
104
N/A
Biotechnology & Life Sciences
Healthcare
US
Westlake Village
